Immunocytochemical demonstration of rabbit ribonuclease and phospholipase A2 by the peroxidase-antiperoxidase technique in professional phagocytes (pulmonary alveolar macrophages and granulocytic and mononuclear peritoneal exudate cells) and in glycol methacrylate sections of dermal tuberculous (BCG) lesions.
Acid-acting (pH 6-7) (presumably lysosomal) ribonuclease and neutral-acting (pH 7-8) calcium-dependent phospholipase A2 (presumably the enzyme releasing arachidonic acid from membrane phospholipids) were demonstrated by the peroxidase-antiperoxidase (PAP) immunocytochemical technique in rabbit professional phagocytes: pulmonary alveolar macrophages (AM), oil-induced peritoneal exudate macrophages (M phi) and glycogen-induced peritoneal exudate polymorphonuclear granulocytes (PMN). All three cell types stained positively with antisera to purified rabbit lung RNase and purified rabbit granulocyte phospholipase A2. The RNase and phospholipase A2 were also demonstrated by the PAP technique in the activated macrophages and granulocytes present in tissue sections of tuberculous (BCG) lesions. The intensity of staining of these two enzymes in individual macrophages did not change appreciably as the BCG lesions developed and regressed, but there were more macrophages rich in both enzymes when the lesions reached their peak size at 21 days. When the anti-RNase serum was fractionated by immunoabsorbent chromatography, the anti-delta RNase serum fraction stained exudate M phi and PMN better than AM; and the anti-beta RNase fraction stained AM better than M phi and PMN. Similar to isolated phagocytes, tissue granulocytes stained best with the anti-delta fraction; and activated tissue macrophages stained best with the anti-beta fraction. Thus, macrophages and granulocytes contain two types of RNase, beta and delta; and the beta RNase is associated with macrophage activation.
D000818:Animals; D001202:Ascitic Fluid / Q000276:immunology; D001500:BCG Vaccine / Q000008:administration & dosage; D006098:Granulocytes / Q000201:enzymology / Q000276:immunology; D006651:Histocytochemistry; D007106:Immune Sera / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D008262:Macrophage Activation; D008264:Macrophages / Q000201:enzymology / Q000276:immunology; D010586:Phagocytes / Q000201:enzymology / Q000276:immunology*; D010740:Phospholipases / Q000276:immunology*; D010741:Phospholipases A / Q000276:immunology*; D054467:Phospholipases A2; D011102:Polyhydroxyethyl Methacrylate; D011650:Pulmonary Alveoli / Q000473:pathology; D011817:Rabbits; D012260:Ribonucleases / Q000276:immunology*; D014382:Tuberculosis, Cutaneous / Q000209:etiology / Q000276:immunology* / Q000473:pathology
D001500:BCG Vaccine; D007106:Immune Sera; D011102:Polyhydroxyethyl Methacrylate; D010740:Phospholipases; D012260:Ribonucleases; D010741:Phospholipases A; D054467:Phospholipases A2